BRK-B vs CIA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CIA exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally low Debt/Equity ratio of 0.03. The stock is currently trading at $5.71, which is slightly above its Graham Number ($5.43) but significantly below its growth-based intrinsic value of $8.26. While explosive year-over-year earnings growth (99.5%) and consistent earnings beats provide a strong fundamental catalyst, the outlook is tempered by a heavily bearish technical trend (10/100) and a lack of dividend yield. The company is essentially a growth-oriented small-cap insurance play with strong momentum in earnings surprises but weak price action trends.
Compare Another Pair
Related Comparisons
BRK-B vs CIA: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Citizens, Inc. (CIA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.